{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:04:14Z","timestamp":1790773454862,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Ankylosing spondylitis (AS) is the prototype of a group of systemic inflammatory diseases referred to as spondyloarthritis. Comorbid inflammatory bowel disease and changed gut microbiota in AS have attracted attention to the influence of gut\u2013joint axis and encouraged treating AS by targeting gut microbiota. Here we first reported a patient with refractory AS and comorbid ulcerative colitis (UC) who underwent three fecal microbiota transplantations (FMTs). Inadequate response to conventional treatments including tumor necrosis factor inhibitors impelled FMT as alternative therapy. Notable improvements in AS and UC accompanied with changed fecal microbiota were recorded at 1 week post-FMT1. Further recovery was found after the other two FMTs, and a roughly stable status was maintained in the follow-up period. More studies are needed to validate the effectiveness of FMT in AS and its mechanisms.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1093233","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:36:21Z","timestamp":1677155781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis"],"prefix":"10.3389","volume":"14","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac064","article-title":"Symptoms compatible with Rome IV functional bowel disorder in patients with ankylosing spondylitis","volume":"21","author":"Wang","year":"2022","journal-title":"Mod Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"151925","DOI":"10.1016\/j.semarthrit.2021.11.002","article-title":"Gut microbiota changes in patients with spondyloarthritis: A systematic review","volume":"52","author":"Wang","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141868","article-title":"PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis","volume":"5","author":"Hsieh","year":"2020","journal-title":"JCI Insight"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39681","article-title":"Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis","volume":"68","author":"Asquith","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.40154","article-title":"Role of gut inflammation in altering the monocyte compartment and its osteoclastogenic potential in HLA-B27-Transgenic rats","volume":"69","author":"Ansalone","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.04.038","article-title":"The correlation between intestinal dysbiosis and the development of ankylosing spondylitis","volume":"132","author":"Zhang","year":"2019","journal-title":"Microb Pathog"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.40582","article-title":"Proinflammatory CX3CR1+CD59+Tumor necrosis factor-like molecule 1A+Interleukin-23+ monocytes are expanded in patients with ankylosing spondylitis and modulate innate lymphoid cell 3 immune functions","volume":"70","author":"Ciccia","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.41018","article-title":"Novel inter-omic analysis reveals relationships between diverse gut microbiota and host immune dysregulation in HLA-B27-Induced experimental spondyloarthritis","volume":"71","author":"Gill","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.587119","article-title":"Multi 'Omics analysis of intestinal tissue in ankylosing spondylitis identifies alterations in the tryptophan metabolism pathway","volume":"12","author":"Berlinberg","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-13-110","article-title":"Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: the potential role of interleukin-10","volume":"13","author":"Capkova","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the new York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.742255","article-title":"Long-term efficacy of low-intensity single donor fecal microbiota transplantation in ulcerative colitis and outcome-specific gut bacteria","volume":"12","author":"Ren","year":"2021","journal-title":"Front Microbiol"},{"key":"B14","article-title":"Faecal microbiota transplantation for clostridium difficile infection resulting in a decrease in psoriatic arthritis disease activity","volume":"37","author":"Selvanderan","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3677","article-title":"Fecal microbiota transplantation for rheumatoid arthritis: A case report","volume":"9","author":"Zeng","year":"2020","journal-title":"Clin Case Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.00108","article-title":"Incidental benefits after fecal microbiota transplant for ulcerative colitis","volume":"18","author":"Mahajan","year":"2020","journal-title":"Intest Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219511","article-title":"Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial","volume":"80","author":"Kragsnaes","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10151-020-02395-3","article-title":"Fecal microbiota transplantation for crohn's disease: a systematic review and meta-analysis","volume":"25","author":"Cheng","year":"2021","journal-title":"Tech Coloproctol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13104-018-3293-x","article-title":"Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing enterobacteriaceae: a proof of principle study","volume":"11","author":"Singh","year":"2018","journal-title":"BMC Res Notes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.11.014","article-title":"Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities","volume":"53","author":"Sa\u00efdani","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.07.038","article-title":"Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activity","volume":"497","author":"Zhang","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215763","article-title":"Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition","volume":"79","author":"Yin","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B23","first-page":"99","article-title":"Dynamic variations in gut microbiota in ankylosing spondylitis patients treated with anti-TNF-\u03b1 for six months","volume":"50","author":"Zhang","year":"2020","journal-title":"Ann Clin Lab Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8884324","article-title":"The association of fecal microbiota in ankylosing spondylitis cases with c-reactive protein and erythrocyte sedimentation rate","volume":"2020","author":"Liu","year":"2020","journal-title":"Mediators Inflamm"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00176-18","article-title":"Altered bacterial-fungal interkingdom networks in the guts of ankylosing spondylitis patients","volume":"4","author":"Li","year":"2019","journal-title":"mSystems"},{"key":"B26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.21037\/atm.2019.09.41","article-title":"Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis","volume":"7","author":"Chen","year":"2019","journal-title":"Ann Transl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy182","article-title":"Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1","volume":"24","author":"Zhou","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020391","article-title":"Molecules produced by probiotics and intestinal microorganisms with immunomodulatory activity","volume":"12","author":"Delgado","year":"2020","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa835","article-title":"The oral and gut microbiome in rheumatoid arthritis patients: a systematic review","volume":"60","author":"Chu","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.38967","article-title":"Brief report: Intestinal dysbiosis in ankylosing spondylitis","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1099\/jmm.0.001107","article-title":"Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment","volume":"69","author":"Huang","year":"2020","journal-title":"J Med Microbiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2020.101340","article-title":"Sleep, circadian rhythm, and gut microbiota","volume":"53","author":"Matenchuk","year":"2020","journal-title":"Sleep Med Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04976-x","article-title":"Fatigue and contributing factors in Chinese patients with ankylosing spondylitis","volume":"39","author":"Zhou","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/nu14224730","article-title":"Diet and disease activity in patients with axial spondyloarthritis: SpondyloArthritis and NUTrition study (SANUT)","volume":"14","author":"Vergne-Salle","year":"2022","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12623","article-title":"Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis","volume":"5","author":"Bryant","year":"2021","journal-title":"JGH Open"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2020.109288","article-title":"Stachyose increases intestinal barrier through akkermansia muciniphila and reduces gut inflammation in germ-free mice after human fecal transplantation","volume":"137","author":"Xi","year":"2020","journal-title":"Food Res Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01153","article-title":"NSAID-gut microbiota interactions","volume":"11","author":"Maseda","year":"2020","journal-title":"Front Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700570","article-title":"Adalimumab therapy restores the gut microbiota in patients with ankylosing spondylitis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1093233\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:36:26Z","timestamp":1677155786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1093233\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2023.1093233"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1093233","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"1093233"}}